|
|
Mitsuhiro Watanabe, Sander M. Houten, Li Wang, Antonio Moschetta, David J. Mangelsdorf, Richard A. Heyman, David D. Moore, Johan Auwerx
J Clin Invest. 2004;
113(10):1408
doi:10.1172/JCI21025
Abstract |
Full text
| PDF
W
e explored the effects of bile acids on triglyceride (TG) homeostasis using a combination of molecular, cellular, and animal models. Cholic acid (CA) prevents hepatic TG accumulation, VLDL secretion, and elevated serum TG in mouse models of hypertriglyceridemia. At the molecular level, CA decreases hepatic expression of SREBP-1c and its lipogenic target genes. Through the use of mouse mutants for the short heterodimer partner (SHP) and liver X receptor (LXR) α and β, we demonstrate the critical dependence of the reduction of SREBP-1c expression by either natural or synthetic farnesoid X receptor (FXR) agonists on both SHP and LXRα and LXRβ. These results suggest that strategies aimed at increasing FXR activity and the repressive effects of SHP should be explored to correct hypertriglyceridemia.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(27)
| Title and authors |
Publication |
Year |
Abnormalities of lipid metabolism, gallstone disease and gallbladder function
Silvana Zanlungo, Attilio Rigotti, Juan Francisco Miquel, Flavio Nervi
|
Clinical Lipidology
|
2011 |
Sterol Regulation of Metabolism, Homeostasis, and Development
Joshua Wollam, Adam Antebi
|
Annu. Rev. Biochem.
|
2011 |
Tumor suppressor p53 regulates bile acid homeostasis via small heterodimer partner
D.-H. Kim, J. W. Lee
|
Proceedings of the National Academy of Sciences
|
2011 |
Ursodeoxycholic acid treatment of hepatic steatosis: a 13C NMR metabolic study
Patrícia M. Nunes, John G. Jones, Anabela P. Rolo, Carlos M. M. Palmeira, Rui A. Carvalho
|
NMR Biomed.
|
2011 |
Role of small heterodimer partner in lipid homeostasis and its potential as a therapeutic target for obesity
Li Wang
|
Clinical Lipidology
|
2010 |
Colloquium Paper: Systemic gut microbial modulation of bile acid metabolism in host tissue compartments
J. R. Swann, E. J. Want, F. M. Geier, K. Spagou, I. D. Wilson, J. E. Sidaway, J. K. Nicholson, E. Holmes
|
Proceedings of the National Academy of Sciences
|
2010 |
Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
Giovanni Musso, Roberto Gambino, Maurizio Cassader
|
Annu. Rev. Med.
|
2010 |
Upregulation of scavenger receptor class B type I expression by activation of FXR in hepatocyte
Fan Chao, Wei Gong, Yingru Zheng, Yuan Li, Gang Huang, Min Gao, Jialin Li, Ramalinga Kuruba, Xiang Gao, Song Li, Fengtian He
|
Atherosclerosis
|
2010 |
A new life for bile acids
Peter L.M. Jansen
|
Journal of Hepatology
|
2010 |
Farnesoid X receptor as a therapeutic target for dyslipidemia
Mark J Evans, Stephen J Gardell
|
Clinical Lipidology
|
2009 |
|
